A randomised study of the use of a customised immobilisation system in the treatment of prostate cancer with conformal radiotherapy
Christopher M. Nutting(Institute of Cancer Research), D.P. Dearnaley(Royal Marsden NHS Foundation Trust), A. Norman(Royal Marsden NHS Foundation Trust), Vincent Khoo(The University of Texas MD Anderson Cancer Center), Vicky Walker(Institute of Cancer Research), H. McNair(Institute of Cancer Research), Charlotte Beardmore(Institute of Cancer Research)
Cited by 53
Related Papers
Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
|New England Journal of Medicine|2008|2.3k
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
|European Journal of Heart Failure|2020|767
Cardiovascular Disease as a Long-Term Complication of Treatment for Testicular Cancer
|Journal of Clinical Oncology|2003|548
Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience
|International Journal of Radiation Oncology*Biology*Physics|1999|468
Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial.
|Journal of Clinical Oncology|1997|334